Skip to main content
. 2018 Sep 12;194(1):27–38. doi: 10.1111/cei.13180

Table 4.

Poisson regression models to establish empirical relations with damage accrual (global SDI score)

Univariate model Multiple model
ORa 95% CI Pseudo‐R 2 OR 95% CI
Disease duration 1·035 1·029−1·040 0·124 1·020 1·014−1·026
Age 1·036 1·031−1·040 0·230 1·034 1·029−1·040
Ever smoker 1·422 1·244−1·626 0·017 1·175 1·019−1·355
Lupus nephritis 1·232 1·076−1·410 0·003 1·498 1·289−1·742
Daily prednisolone dose ≥ 7·5 mg (ongoing) 1·325 1·151−1·526 0·008 1·727 1·485−2·008
Statins (ongoing) 1·822 1·488−2·230 0·023 1·249 1·013−1·539
LA positivity 1·521 1·315−1·760 0·171 1·268 1·092−1·471
HCQ (ongoing) 0·686 0·598−0·787 0·021 0·851 0·732−0·989
Hypertension 1·367 1·175−1·589 0·024
Triple positivity 1·298 1·058−1·593 <0·001
Total pseudo‐R 2 (multiple model) 0·471

Pseudo‐R 2 is different from the R 2 used in ordinary least‐squares regression models. However, it will give an approximation of how well the independent variables are related with the outcome [sum of global SLICC/ACR damage index (SDI)]. CI = confidence intervals.

a

The odds ratios (OR) can be interpreted as follows: an increase of 1 year of disease duration is associated with 3·5% higher score (OR = 1·035) in the number of SDI points, and ongoing treatment with hydroxychloroquine (HCQ) is associated with 31·4% less score (OR = 0·686, 1–0·686 = 0·314) in the sum of global SDI score compared to those not having ongoing treatment with HCQ.